China Medical System Holdings Stock | 867.HK | KYG211081248 | A1JLYP

Date	China Medical System Holdings Price
9/10/2024	6.31 CNY
9/9/2024	6.32 CNY
9/5/2024	6.48 CNY
9/4/2024	6.48 CNY
9/3/2024	6.49 CNY
9/2/2024	6.54 CNY
8/30/2024	6.48 CNY
8/29/2024	6.53 CNY
8/28/2024	6.54 CNY
8/27/2024	6.57 CNY
8/26/2024	6.45 CNY
8/23/2024	6.32 CNY
8/22/2024	6.51 CNY
8/21/2024	6.47 CNY
8/20/2024	6.50 CNY
8/19/2024	6.59 CNY
8/16/2024	6.64 CNY
8/15/2024	6.12 CNY
8/14/2024	6.07 CNY
8/13/2024	6.22 CNY

Date	China Medical System Holdings Revenue	China Medical System Holdings EBIT	China Medical System Holdings Net Income
2027e	12.73 B CNY	4 B CNY	3.29 B CNY
2026e	10.7 B CNY	3.4 B CNY	2.85 B CNY
2025e	9.15 B CNY	2.43 B CNY	2.04 B CNY
2024e	8 B CNY	2.06 B CNY	1.77 B CNY
2023	8.01 B CNY	2.72 B CNY	2.4 B CNY
2022	9.15 B CNY	3.64 B CNY	3.26 B CNY
2021	8.34 B CNY	3.22 B CNY	3.02 B CNY
2020	6.95 B CNY	2.81 B CNY	2.53 B CNY
2019	6.07 B CNY	2.4 B CNY	1.96 B CNY
2018	5.43 B CNY	2.01 B CNY	1.85 B CNY
2017	5.35 B CNY	1.9 B CNY	1.67 B CNY
2016	4.9 B CNY	1.55 B CNY	1.38 B CNY
2015	3.55 B CNY	1.07 B CNY	995.94 M CNY
2014	2.95 B CNY	1.12 B CNY	1.05 B CNY
2013	2.25 B CNY	701.6 M CNY	636.2 M CNY
2012	1.78 B CNY	580.8 M CNY	536.5 M CNY
2011	1.36 B CNY	402.6 M CNY	402.4 M CNY
2010	894.6 M CNY	237.8 M CNY	207 M CNY
2009	658.8 M CNY	187.4 M CNY	141.3 M CNY
2008	504.5 M CNY	128.4 M CNY	103.9 M CNY
2007	393.5 M CNY	92.4 M CNY	66 M CNY
2006	300 M CNY	44 M CNY	32 M CNY
2005	271.1 M CNY	55.1 M CNY	40 M CNY
2004	227.3 M CNY	48.2 M CNY	29.6 M CNY

	Revenue	EBIT	Net Income
2004	227.3 M CNY	48.2 M CNY	29.6 M CNY
2005	271.1 M CNY	55.1 M CNY	40 M CNY
2006	300 M CNY	44 M CNY	32 M CNY
2007	393.5 M CNY	92.4 M CNY	66 M CNY
2008	504.5 M CNY	128.4 M CNY	103.9 M CNY
2009	658.8 M CNY	187.4 M CNY	141.3 M CNY
2010	894.6 M CNY	237.8 M CNY	207 M CNY
2011	1.36 B CNY	402.6 M CNY	402.4 M CNY
2012	1.78 B CNY	580.8 M CNY	536.5 M CNY
2013	2.25 B CNY	701.6 M CNY	636.2 M CNY
2014	2.95 B CNY	1.12 B CNY	1.05 B CNY
2015	3.55 B CNY	1.07 B CNY	995.94 M CNY
2016	4.9 B CNY	1.55 B CNY	1.38 B CNY
2017	5.35 B CNY	1.9 B CNY	1.67 B CNY
2018	5.43 B CNY	2.01 B CNY	1.85 B CNY
2019	6.07 B CNY	2.4 B CNY	1.96 B CNY
2020	6.95 B CNY	2.81 B CNY	2.53 B CNY
2021	8.34 B CNY	3.22 B CNY	3.02 B CNY
2022	9.15 B CNY	3.64 B CNY	3.26 B CNY
2023	8.01 B CNY	2.72 B CNY	2.4 B CNY
2024e	8 B CNY	2.06 B CNY	1.77 B CNY
2025e	9.15 B CNY	2.43 B CNY	2.04 B CNY
2026e	10.7 B CNY	3.4 B CNY	2.85 B CNY
2027e	12.73 B CNY	4 B CNY	3.29 B CNY

2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0.03	0.04	0.07	0.13	0.14	0.1	0.88	0.62	0.67	0.49	0.24	0.51	0.48	0.86	0.82	1.37	2.67	4.36	5.87	6.14
0.09	0.11	0.07	0.13	0.17	0.21	0.28	0.4	0.31	0.38	0.58	0.74	1.07	0.99	1.28	1	1.05	1.4	1.44	1.15
0	0	0.01	0.02	0.02	0.02	0.03	0.04	0.24	0.24	0.29	0.46	1.46	0.6	0.54	0.67	0.74	0.93	0.79	0.72
15	13	13	78	41	75	105	132	96	167	189.46	385.18	509	460.4	434.66	407.06	381.22	472.6	477.21	637.64
0	0	0	0	7	120	45	262	492	684	35.23	23.76	35.95	51.7	72.86	101.23	137.41	213.13	253.77	148.94
0.14	0.17	0.17	0.35	0.38	0.53	1.35	1.46	1.81	1.96	1.34	2.11	3.55	2.96	3.15	3.55	4.98	7.38	8.83	8.79
0.03	0.03	0.04	0.04	0.04	0.02	0.03	0.12	0.15	0.32	0.34	0.45	0.51	0.55	0.57	0.86	1.16	1.32	1.78	1.49
0	0	0	0	0	0.01	0.01	0.01	0.11	0.13	1.31	1.32	1.36	2.44	2.73	2.86	3.06	3.09	3.34	3.61
0	0	0	0	0	0	0	0	0	0	0	10.64	10.96	0	0	31.82	30	61.88	30	30
0	0	0	0	0.05	0.04	0.04	0.21	0.22	0.24	0.44	1.03	2.89	2.72	2.55	2.46	2.24	2.22	2.07	2.22
0	0	0	0	0	0	0	1.12	1.11	1.19	1.18	1.38	1.38	1.38	1.38	1.38	1.21	1.69	1.67	1.55
5	5	4	5	9	12	50	58	46	80	70.5	86.28	91.09	97.77	115.25	20.3	22.44	51.3	39.01	40.4
0.03	0.04	0.04	0.05	0.11	0.09	0.12	1.53	1.64	1.96	3.35	4.28	6.24	7.19	7.36	7.62	7.72	8.43	8.92	8.94
0.17	0.2	0.21	0.4	0.48	0.62	1.47	2.98	3.44	3.92	4.68	6.4	9.79	10.15	10.51	11.17	12.7	15.81	17.75	17.73

84	0	0	35	32	32	38	51	75	83	82.97	85.2	85.2	85.2	84.96	84.96	84.63	84.18	83.99	83.99
0	0	0	0.13	0.12	0.04	0.83	1.7	1.66	1.77	1.77	2.44	2.44	2.44	2.39	2.39	2.3	2.15	2.11	2.11
-0.01	-0.01	0.1	0.13	0.17	0.25	0.39	0.6	0.95	1.4	2.15	2.78	3.69	4.75	5.87	7.01	8.71	10.61	12.59	13.64
0	3	8	20	39	44	55	95	100	-11	-9.2	-9.21	-8.89	-4.01	22.81	17.45	-21.25	-27.6	52.13	65.05
0	0	0	0	0	0	0	0	13	29	0	0	0	-3.27	-17.34	-31.86	-41.19	-66.5	-242.02	-371.96
0.08	-0	0.1	0.31	0.36	0.37	1.32	2.45	2.79	3.26	3.99	5.3	6.21	7.27	8.36	9.47	11.03	12.75	14.59	15.52
65	94	36	94	63	53	36	129	111	151	79.22	208.44	137.59	130.01	106.13	44.04	134.81	145.9	178.01	578.64
0	0	0	0	0	22	19	49	46	64	75.97	94.6	270.37	251.72	228.26	309.36	450.4	464.36	367.69	281.08
0.01	0.1	0.04	0	0.01	0.02	0.03	0.04	0.02	0.06	0.05	0.14	1.38	0.21	0.19	0.49	0.32	0.35	0.53	0.34
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.27
0.01	0.01	0.03	0	0	0.11	0.03	0.25	0.4	0.31	0.48	0.46	1.61	0.07	0.03	0.7	0.01	1.12	1.8	0.02
0.08	0.2	0.11	0.1	0.07	0.2	0.11	0.47	0.58	0.59	0.69	0.9	3.4	0.66	0.55	1.55	0.91	2.08	2.88	2.49
0	0	0	0	0	0	0	0	0	0	0	0	0	2.04	1.44	0.01	0.59	0.59	0.01	0.02
0	0	0	0	6	12	14	29	31	29	81.18	108.61	105.56	104.5	101.41	91.55	86.13	123.58	124.96	108.97
0	0	0	0	42	36	30	26	21	22	44.59	33.28	22.04	17.9	9.93	5.1	7.38	164.44	0.91	0
0	0	0	0	0.05	0.05	0.04	0.06	0.05	0.05	0.13	0.14	0.13	2.16	1.55	0.11	0.69	0.88	0.14	0.13
0.08	0.2	0.11	0.1	0.12	0.25	0.15	0.52	0.63	0.64	0.82	1.05	3.52	2.82	2.1	1.65	1.6	2.96	3.02	2.61
0.16	0.2	0.21	0.4	0.48	0.62	1.47	2.97	3.43	3.91	4.81	6.34	9.73	10.1	10.46	11.13	12.63	15.71	17.61	18.13

2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0.05	0.05	0.04	0.08	0.14	0.18	0.23	0.44	0.6	0.69	1.13	1.06	1.5	1.81	2.01	2.49	2.82	3.46	3.76
2	3	3	5	10	13	10	26	32	36	42	77	175	196	198	204	208	219	227
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-7	-27	-9	-56	-75	-93	-191	-53	-178	-380	-101	-530	-559	-26	-488	-67	-358	-992	-360
10	10	26	22	0	1	21	-7	-9	-6	-226	3	45	93	37	-69	26	-189	-76
1	0	0	2	0	0	2	5	16	2	10	25	39	79	70	55	27	17	37
9	17	13	16	25	35	35	34	65	53	67	107	48	160	110	223	446	396	450
0.05	0.04	0.06	0.05	0.07	0.11	0.08	0.41	0.44	0.33	0.84	0.61	1.16	2.07	1.75	2.56	2.69	2.49	3.55
-5	-8	-9	-6	-6	-1	-25	-89	-69	-136	-91	-94	-65	-76	-61	-340	-341	-184	-524
17	-31	31	-14	-12	-113	63	-695	-334	-174	-936	-852	-1,533	-354	-239	-309	-353	-1,519	-1,178
22	-23	40	-8	-5	-111	88	-605	-264	-38	-844	-757	-1,468	-277	-177	31	-12	-1,334	-653
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.01	0	0.02	-0.05	0	0.11	-0.08	0.2	0.15	-0.09	0.17	-0.06	1.13	0.42	-0.69	-0.81	-0.08	1.07	-0.07
0	0	0	152	0	3	839	10	0	0	0	678	0	0	-53	0	-86	-151	-48
-58	-1	-60	23	-50	-27	662	42	-52	-344	-149	219	621	-1,345	-1,554	-1,695	-1,034	-258	-1,399
-1.00	-	-80.00	-74.00	-1.00	-78.00	-61.00	-5.00	-25.00	-8.00	-29.00	-31.00	-47.00	-1,152.00	-79.00	-63.00	-37.00	-17.00	-5.00
-69	0	0	0	-49	-64	-32	-163	-179	-242	-291	-369	-462	-611	-728	-822	-834	-1,154	-1,276
0.01	0.01	0.04	0.07	0.02	-0.03	0.8	-0.23	0.06	-0.19	-0.24	-0.01	0.25	0.37	-0.04	0.55	1.3	0.72	0.99
46.6	31.4	54.7	44	64	104.3	50.3	316.3	370.9	198.2	751.54	519.92	1,097	1,995.17	1,692.59	2,214.65	2,350.61	2,309.01	3,028.32
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

China Medical System Holdings Gross margin	China Medical System Holdings Profit margin	China Medical System Holdings EBIT margin	China Medical System Holdings Profit margin
2027e	76.24 %	31.4 %	25.87 %
2026e	76.24 %	31.73 %	26.63 %
2025e	76.24 %	26.54 %	22.28 %
2024e	76.24 %	25.73 %	22.12 %
2023	76.24 %	33.89 %	29.96 %
2022	76.89 %	39.76 %	35.62 %
2021	74.93 %	38.59 %	36.19 %
2020	73.92 %	40.43 %	36.43 %
2019	74.85 %	39.58 %	32.28 %
2018	72.09 %	37.06 %	34.05 %
2017	65.03 %	35.46 %	31.31 %
2016	59.42 %	31.53 %	28.08 %
2015	57.58 %	30.11 %	28.03 %
2014	56.18 %	37.99 %	35.51 %
2013	54.53 %	31.2 %	28.29 %
2012	58.82 %	32.66 %	30.17 %
2011	56.62 %	29.61 %	29.6 %
2010	59.09 %	26.58 %	23.14 %
2009	63.1 %	28.45 %	21.45 %
2008	61.67 %	25.45 %	20.59 %
2007	64.93 %	23.48 %	16.77 %
2006	68.9 %	14.67 %	10.67 %
2005	74.14 %	20.32 %	14.75 %
2004	76.46 %	21.21 %	13.02 %

	Gross margin	EBIT margin	Profit margin
2004	76.46 %	21.21 %	13.02 %
2005	74.14 %	20.32 %	14.75 %
2006	68.9 %	14.67 %	10.67 %
2007	64.93 %	23.48 %	16.77 %
2008	61.67 %	25.45 %	20.59 %
2009	63.1 %	28.45 %	21.45 %
2010	59.09 %	26.58 %	23.14 %
2011	56.62 %	29.61 %	29.6 %
2012	58.82 %	32.66 %	30.17 %
2013	54.53 %	31.2 %	28.29 %
2014	56.18 %	37.99 %	35.51 %
2015	57.58 %	30.11 %	28.03 %
2016	59.42 %	31.53 %	28.08 %
2017	65.03 %	35.46 %	31.31 %
2018	72.09 %	37.06 %	34.05 %
2019	74.85 %	39.58 %	32.28 %
2020	73.92 %	40.43 %	36.43 %
2021	74.93 %	38.59 %	36.19 %
2022	76.89 %	39.76 %	35.62 %
2023	76.24 %	33.89 %	29.96 %
2024e	76.24 %	25.73 %	22.12 %
2025e	76.24 %	26.54 %	22.28 %
2026e	76.24 %	31.73 %	26.63 %
2027e	76.24 %	31.4 %	25.87 %

Date	China Medical System Holdings Sales per Share	China Medical System Holdings EBIT per share	China Medical System Holdings Earnings per Share
2027e	5.27 CNY	0 CNY	1.36 CNY
2026e	4.43 CNY	0 CNY	1.18 CNY
2025e	3.79 CNY	0 CNY	0.84 CNY
2024e	3.31 CNY	0 CNY	0.73 CNY
2023	3.27 CNY	1.11 CNY	0.98 CNY
2022	3.73 CNY	1.48 CNY	1.33 CNY
2021	3.38 CNY	1.3 CNY	1.22 CNY
2020	2.81 CNY	1.14 CNY	1.02 CNY
2019	2.45 CNY	0.97 CNY	0.79 CNY
2018	2.19 CNY	0.81 CNY	0.74 CNY
2017	2.15 CNY	0.76 CNY	0.67 CNY
2016	1.97 CNY	0.62 CNY	0.55 CNY
2015	1.44 CNY	0.43 CNY	0.4 CNY
2014	1.22 CNY	0.46 CNY	0.43 CNY
2013	0.93 CNY	0.29 CNY	0.26 CNY
2012	0.74 CNY	0.24 CNY	0.22 CNY
2011	0.58 CNY	0.17 CNY	0.17 CNY
2010	0.45 CNY	0.12 CNY	0.1 CNY
2009	0.46 CNY	0.13 CNY	0.1 CNY
2008	0.36 CNY	0.09 CNY	0.07 CNY
2007	0.3 CNY	0.07 CNY	0.05 CNY
2006	0.21 CNY	0.03 CNY	0.02 CNY
2005	0.19 CNY	0.04 CNY	0.03 CNY
2004	0.16 CNY	0.03 CNY	0.02 CNY

	Sales per Share	EBIT per share	Earnings per Share
2004	0.16 CNY	0.03 CNY	0.02 CNY
2005	0.19 CNY	0.04 CNY	0.03 CNY
2006	0.21 CNY	0.03 CNY	0.02 CNY
2007	0.3 CNY	0.07 CNY	0.05 CNY
2008	0.36 CNY	0.09 CNY	0.07 CNY
2009	0.46 CNY	0.13 CNY	0.1 CNY
2010	0.45 CNY	0.12 CNY	0.1 CNY
2011	0.58 CNY	0.17 CNY	0.17 CNY
2012	0.74 CNY	0.24 CNY	0.22 CNY
2013	0.93 CNY	0.29 CNY	0.26 CNY
2014	1.22 CNY	0.46 CNY	0.43 CNY
2015	1.44 CNY	0.43 CNY	0.4 CNY
2016	1.97 CNY	0.62 CNY	0.55 CNY
2017	2.15 CNY	0.76 CNY	0.67 CNY
2018	2.19 CNY	0.81 CNY	0.74 CNY
2019	2.45 CNY	0.97 CNY	0.79 CNY
2020	2.81 CNY	1.14 CNY	1.02 CNY
2021	3.38 CNY	1.3 CNY	1.22 CNY
2022	3.73 CNY	1.48 CNY	1.33 CNY
2023	3.27 CNY	1.11 CNY	0.98 CNY
2024e	3.31 CNY	0 CNY	0.73 CNY
2025e	3.79 CNY	0 CNY	0.84 CNY
2026e	4.43 CNY	0 CNY	1.18 CNY
2027e	5.27 CNY	0 CNY	1.36 CNY

	Number of stocks
2004	1.42 B Aktien
2005	1.42 B Aktien
2006	1.42 B Aktien
2007	1.31 B Aktien
2008	1.42 B Aktien
2009	1.43 B Aktien
2010	2 B Aktien
2011	2.36 B Aktien
2012	2.41 B Aktien
2013	2.41 B Aktien
2014	2.41 B Aktien
2015	2.47 B Aktien
2016	2.49 B Aktien
2017	2.49 B Aktien
2018	2.49 B Aktien
2019	2.48 B Aktien
2020	2.47 B Aktien
2021	2.47 B Aktien
2022	2.45 B Aktien
2023	2.45 B Aktien
2024e	2.45 B Aktien
2025e	2.45 B Aktien
2026e	2.45 B Aktien
2027e	2.45 B Aktien

Date	China Medical System Holdings Dividend
2027e	0.69 CNY
2026e	0.69 CNY
2025e	0.69 CNY
2024e	0.69 CNY
2023	0.62 CNY
2022	0.62 CNY
2021	0.56 CNY
2020	0.37 CNY
2019	0.38 CNY
2018	0.35 CNY
2017	0.28 CNY
2016	0.22 CNY
2015	0.17 CNY
2014	0.08 CNY
2013	0.02 CNY
2012	0.01 CNY
2011	0.01 CNY

	Dividend	Dividend (Estimate)
2004	0 CNY	0 CNY
2005	0 CNY	0 CNY
2006	0 CNY	0 CNY
2007	0 CNY	0 CNY
2008	0 CNY	0 CNY
2009	0 CNY	0 CNY
2010	0 CNY	0 CNY
2011	0.01 CNY	0 CNY
2012	0.01 CNY	0 CNY
2013	0.02 CNY	0 CNY
2014	0.08 CNY	0 CNY
2015	0.17 CNY	0 CNY
2016	0.22 CNY	0 CNY
2017	0.28 CNY	0 CNY
2018	0.35 CNY	0 CNY
2019	0.38 CNY	0 CNY
2020	0.37 CNY	0 CNY
2021	0.56 CNY	0 CNY
2022	0.62 CNY	0 CNY
2023	0.62 CNY	0 CNY
2024e	0 CNY	0.69 CNY
2025e	0 CNY	0.69 CNY
2026e	0 CNY	0.69 CNY
2027e	0 CNY	0.69 CNY

Date	China Medical System Holdings Payout ratio
2027e	44.66 %
2026e	44.22 %
2025e	44.76 %
2024e	45.02 %
2023	42.87 %
2022	46.38 %
2021	45.8 %
2020	36.44 %
2019	47.82 %
2018	46.9 %
2017	42.03 %
2016	39.59 %
2015	40.99 %
2014	17.67 %
2013	6.2 %
2012	5.36 %
2011	6.59 %
2010	42.87 %
2009	42.87 %
2008	42.87 %
2007	42.87 %
2006	42.87 %
2005	42.87 %
2004	42.87 %

	Payout ratio
2004	42.87 %
2005	42.87 %
2006	42.87 %
2007	42.87 %
2008	42.87 %
2009	42.87 %
2010	42.87 %
2011	6.59 %
2012	5.36 %
2013	6.2 %
2014	17.67 %
2015	40.99 %
2016	39.59 %
2017	42.03 %
2018	46.9 %
2019	47.82 %
2020	36.44 %
2021	45.8 %
2022	46.38 %
2023	42.87 %
2024e	45.02 %
2025e	44.76 %
2026e	44.22 %
2027e	44.66 %

Date	EPS Estimate	EPS Actual	Quarterly report
6/30/2024	0.32 CNY	0.37 CNY (15.41 %)	2024 Q2
12/31/2023	0.55 CNY	0.2 CNY (-64.06 %)	2023 Q4
6/30/2023	0.73 CNY	0.78 CNY (7.81 %)	2023 Q2
12/31/2022	0.64 CNY	0.6 CNY (-6.33 %)	2022 Q4
6/30/2022	0.75 CNY	0.73 CNY (-2.06 %)	2022 Q2
12/31/2021	0.57 CNY	0.56 CNY (-0.28 %)	2021 Q4
6/30/2021	0.62 CNY	0.66 CNY (6.96 %)	2021 Q2
12/31/2020	0.48 CNY	0.51 CNY (4.58 %)	2020 Q4
6/30/2020	0.51 CNY	0.52 CNY (2.38 %)	2020 Q2
12/31/2019	0.42 CNY	0.45 CNY (5.14 %)	2019 Q4
6/30/2019	0.46 CNY	0.47 CNY (1.59 %)	2019 Q2
12/31/2018	0.38 CNY	0.36 CNY (-6.46 %)	2018 Q4
6/30/2018	0.39 CNY	0.39 CNY (-1 %)	2018 Q2
12/31/2017	0.36 CNY	0.35 CNY (-3.35 %)	2017 Q4
6/30/2017	0.33 CNY	0.32 CNY (-0.67 %)	2017 Q2
12/31/2016	0.28 CNY	0.29 CNY (2.55 %)	2016 Q4
6/30/2016	0.27 CNY	0.26 CNY (-1.76 %)	2016 Q2
6/30/2015	0.21 CNY	0.2 CNY (-4.76 %)	2015 Q2
6/30/2014	0.19 CNY	0.17 CNY (-8.08 %)	2014 Q2
12/31/2013	0.13 CNY	0.13 CNY (3.12 %)	2013 Q4
6/30/2013	0.13 CNY	0.13 CNY (3.22 %)	2013 Q2
12/31/2012	0.13 CNY	0.11 CNY (-9.97 %)	2012 Q4

%	Name	Stocks	Change	Date
47.07428 %	Lam (DR. Kong)	1,137,564,000	0	12/31/2022
2.90761 %	Chen (Hongbing)	70,263,225	0	12/31/2022
1.69608 %	The Vanguard Group, Inc.	40,986,293	-725,000	3/31/2024
1.34157 %	BlackRock Institutional Trust Company, N.A.	32,419,523	-497,000	3/31/2024
1.18352 %	Dimensional Fund Advisors, L.P.	28,600,100	350,000	2/29/2024
0.93363 %	Lazard Asset Management, L.L.C.	22,561,399	-24,000	3/31/2024
0.92055 %	California State Teachers Retirement System	22,245,480	-1,874,400	6/30/2023
0.89500 %	Bosera Asset Management Co., Ltd.	21,628,000	5,277,000	12/31/2023
0.74859 %	CTBC Investments Co. Ltd.	18,090,000	272,000	2/29/2024
0.73207 %	BlackRock Advisors (UK) Limited	17,690,637	449,000	3/31/2024
0.71604 %	GF Fund Management Co., Ltd.	17,303,400	10,597,400	12/31/2023
0.69190 %	Nordea Investment Management AB (Denmark)	16,720,000	-303,000	2/29/2024
0.61001 %	Norges Bank Investment Management (NBIM)	14,741,034	3,928,533	12/31/2023
0.56908 %	Fidelity Management & Research Company LLC	13,751,886	-24,843	1/31/2024
0.47221 %	Bankinter, S.A. (Madrid)	11,411,000	2,269,000	12/31/2022
0.47221 %	Bankinter Gestión de Activos, SGIIC S.A.	11,411,000	11,411,000	6/30/2023
0.41286 %	Schroder Investment Management (Hong Kong) Ltd.	9,977,000	-313,000	12/31/2023
0.35686 %	Argenta Asset Management SA	8,623,568	0	6/30/2023
0.33991 %	Handelsbanken Kapitalförvaltning AB	8,214,000	0	3/31/2024
0.30283 %	Florida State Board of Administration	7,318,000	-2,004,000	9/30/2022
0.29986 %	Chen (Yanling)	7,246,250	0	12/31/2022
0.25797 %	Geode Capital Management, L.L.C.	6,234,000	-9,000	2/29/2024
0.25421 %	China Asset Management Co., Ltd.	6,143,000	3,337,000	12/31/2023
0.24829 %	INVESCO Great Wall Fund Management Co. Ltd.	6,000,000	-9,000	12/31/2023
0.23443 %	Guinness Atkinson Asset Management Inc.	5,665,000	0	3/31/2024
0.22603 %	UBS SDIC Fund Management Co., Ltd.	5,462,000	-1,709,000	12/31/2023
0.22261 %	Goldman Sachs Asset Management, L.P.	5,379,455	-35,076	3/31/2024
0.20213 %	APG Asset Management N.V.	4,884,493	-2,078,854	9/30/2023
0.19552 %	Aviva Investors Global Services Limited	4,724,717	-172,955	2/29/2024
0.19165 %	Zürcher Kantonalbank (Asset Management)	4,631,185	-32,000	2/29/2024
0.19031 %	Jupiter Asset Management Ltd.	4,599,000	450,000	12/31/2023
0.18767 %	Amundi Asset Management, SAS	4,535,000	3,552,000	3/31/2024
0.17595 %	Artemis Investment Management LLP	4,252,000	-21,000	12/31/2023
0.16970 %	Fidelity Institutional Asset Management	4,100,777	108,868	8/31/2023
0.16935 %	State Street Global Advisors (US)	4,092,390	-53,000	3/31/2024
0.16919 %	Swedbank Robur Fonder AB	4,088,430	0	2/29/2024
0.16424 %	American Century Investment Management, Inc.	3,969,000	612,000	3/31/2024
0.16335 %	Northern Trust Global Investments Limited	3,947,369	0	2/29/2024
0.16012 %	Robeco Institutional Asset Management B.V.	3,869,425	-263,000	3/31/2024
0.14254 %	Nordea Funds Oy	3,444,517	-73,000	2/29/2024
0.13896 %	UBS Asset Management (UK) Ltd.	3,358,000	1,824,000	3/31/2024
0.13385 %	Dimensional Fund Advisors, Ltd.	3,234,500	24,000	2/29/2024
0.12997 %	Goldman Sachs Asset Management International	3,140,800	0	12/31/2023
0.12744 %	Mediolanum International Funds Limited	3,079,696	-62,098	12/31/2023
0.12530 %	Mellon Investments Corporation	3,028,000	474,000	3/31/2024
0.12274 %	CPP Investment Board	2,966,000	2,966,000	3/31/2023
0.12096 %	Royal London Asset Management Ltd.	2,923,000	0	12/31/2023
0.12035 %	Sanlam Investment Management (Pty) Ltd.	2,908,391	-252,000	12/31/2023
0.12027 %	State Street Global Advisors (UK) Ltd.	2,906,407	3	3/31/2024
0.11891 %	State Street Global Advisors Ireland Limited	2,873,400	28,000	3/31/2024
0.11578 %	Allianz Global Investors GmbH	2,797,971	172,000	2/29/2024
0.11405 %	Royal London Asset Management (CIS) Limited_NLE	2,756,000	0	8/31/2023
0.10180 %	E Fund Management Co. Ltd.	2,460,000	774,000	12/31/2023
0.09849 %	Neuberger Berman, LLC	2,380,000	0	5/31/2023
0.09758 %	Credit Suisse Funds AG	2,358,000	60,000	3/31/2024
0.09071 %	Chang Xin Asset Management Co., Ltd.	2,192,000	2,192,000	12/31/2023
0.08709 %	Nikko Asset Management Asia Limited	2,104,666	0	2/29/2024
0.08409 %	Amundi Japan Ltd.	2,032,000	628,000	3/31/2024
0.08355 %	Charles Schwab Investment Management, Inc.	2,018,988	0	3/31/2024
0.08194 %	Tidal Investments LLC	1,980,000	250,000	3/31/2024
0.07917 %	China Asset Management (Hong Kong) Limited	1,913,262	-71,000	3/31/2024
0.07708 %	Nuveen LLC	1,862,660	0	3/31/2024
0.07639 %	BlackRock Investment Management (UK) Ltd.	1,846,000	0	2/29/2024
0.07429 %	DWS Investment GmbH	1,795,213	37,166	3/31/2024
0.07349 %	Allspring Global Investments, LLC	1,776,000	-296,000	2/29/2024
0.07263 %	BlackRock (Singapore) Limited	1,755,132	476,888	3/31/2024
0.07031 %	MFS Investment Management	1,699,000	6,000	3/31/2024
0.06779 %	Northern Trust Investments, Inc.	1,638,248	-9,000	3/31/2024
0.06514 %	DWS Investments UK Limited	1,574,136	21,544	3/31/2024
0.06508 %	Danske Bank Asset Management	1,572,789	0	3/31/2024
0.06472 %	Penghua Fund Management Co., Ltd.	1,564,000	247,000	12/31/2023
0.06211 %	Storebrand Kapitalforvaltning AS	1,501,000	63,000	2/29/2024
0.05764 %	Zhong Ou Asset Management Co., Ltd.	1,393,000	-1,921,000	12/31/2023
0.05549 %	PGGM Vermogensbeheer B.V.	1,340,849	296,517	7/31/2023
0.05504 %	Cambria Investment Management, L.P.	1,330,000	0	7/31/2023
0.05386 %	HSBC Global Asset Management (UK) Limited	1,301,599	9,789	2/29/2024
0.05065 %	UBS Asset Management (Switzerland)	1,224,000	0	2/29/2024
0.04901 %	Mirae Asset Global Investments (Hong Kong) Limited	1,184,280	268,755	3/31/2024
0.04796 %	Evli Fund Management Company Ltd.	1,159,000	0	12/31/2023
0.04774 %	First Trust Advisors L.P.	1,153,760	0	2/29/2024
0.04502 %	Fullgoal Fund Management Co., Ltd.	1,088,000	855,000	12/31/2023
0.04494 %	Pictet Asset Management Ltd.	1,086,000	-66,000	12/31/2023
0.04444 %	Thornbridge Investment Management LLP	1,074,000	0	12/31/2023
0.04341 %	Irish Life Investment Managers Ltd.	1,048,964	200	3/31/2024
0.04151 %	Wanjia Asset Management Co., Ltd.	1,003,000	1,003,000	12/31/2023
0.04126 %	Schroder Investment Management (Singapore) Ltd.	997,000	0	6/30/2023
0.04035 %	Fidelity Investments Canada ULC	974,983	3,772	12/31/2023
0.04031 %	Old Mutual Investment Group (South Africa) (Pty) Limited	974,133	0	2/29/2024
0.04019 %	RAM Active Investments S.A.	971,176	-548,213	12/31/2023
0.03989 %	Lingohr & Partner Asset Management GmbH	964,000	764,000	1/31/2024
0.03947 %	PensionDanmark A/S	953,736	516,944	8/31/2023
0.03945 %	PGIM Quantitative Solutions LLC	953,372	-12,000	2/29/2024
0.03733 %	Goldman Sachs Advisors B.V._NLE	902,000	65,000	11/30/2023
0.03687 %	Wellington Management Company, LLP	890,866	0	2/29/2024
0.03545 %	Danske Capital Finland Oy	856,706	0	10/31/2023
0.03443 %	Mercer Global Investments Management Ltd	832,000	0	3/31/2024
0.03414 %	Yinhua Fund Management Co., Ltd.	825,000	377,000	12/31/2023
0.03294 %	Avantis Investors	796,000	6,000	3/31/2024
0.03253 %	abrdn Investments Limited	786,000	5,000	2/29/2024
0.03221 %	Eurizon Capital S.A.	778,246	-19,859	2/29/2024

Name	Relationship	Two-week correlation	One-month correlation	Three-Month Correlation	Six-Month Correlation	One Year Correlation	Two-Year Correlation
H Lundbeck	SupplierCustomer	0,77	0,43	-0,24	-0,12	0,81	-0,20
Sun Pharmaceutical Inds	SupplierCustomer	0,56	0,09	-0,44	-0,42	-0,83	0,39
AstraZeneca	SupplierCustomer	0,54	0,19	-0,70	-0,69	-0,55	-0,03
Zydus Lifesciences	SupplierCustomer	0,52	0,18	0,30	0,40	0,85	0,75
Cosmo Pharmaceuticals	SupplierCustomer	0,49	-0,33	0,53	0,29	0,86	0,07
Sun Pharma Advanced Rsch	SupplierCustomer	0,43	-0,12	0,54	0,62	-0,22	0,40
Can-Fite BioPharma	SupplierCustomer	0,43	0,13	0,64	0,48	0,92	0,18
Midatech Pharma	SupplierCustomer	-0,40	-0,29	0,62	-	-	-
CytoSorbents	SupplierCustomer	-0,44	-0,56	0,87	0,66	0,78	-0,05
EC	SupplierCustomer	-0,48	-0,01	-0,10	0,26	0,71	0,82

What values and corporate philosophy does China Medical System Holdings represent?

China Medical System Holdings Ltd represents values of integrity, innovation, and excellence in the healthcare industry. With a commitment to providing high-quality pharmaceutical products and healthcare services, the company aims to cater to the medical needs of the Chinese market. China Medical System Holdings Ltd believes in fostering strong relationships with healthcare professionals and partnering with reputable international pharmaceutical companies to ensure the availability of advanced medical solutions. The corporate philosophy of the company centers around delivering sustainable growth and creating long-term value for shareholders while prioritizing the health and well-being of patients in China.

In which countries and regions is China Medical System Holdings primarily present?

China Medical System Holdings Ltd (CMS) is primarily present in the People's Republic of China. As a leading specialty pharma company, CMS focuses on the marketing, promotion, and sales of innovative prescription and over-the-counter pharmaceutical products. With a strong presence in mainland China, CMS has established a widespread distribution network that covers both urban and rural areas. By leveraging its extensive market knowledge and relationships with healthcare providers, CMS effectively serves patients and contributes to improving healthcare standards in China.

What significant milestones has the company China Medical System Holdings achieved?

China Medical System Holdings Ltd has achieved significant milestones since its establishment. The company has successfully expanded its product portfolio by establishing strategic partnerships with renowned pharmaceutical companies. It has also demonstrated impressive sales growth, leading to an increase in market share. China Medical System Holdings Ltd has consistently exhibited strong financial performance, with notable profitability and revenue growth. Additionally, the company has effectively implemented its marketing strategies, resulting in enhanced brand recognition and market penetration. These milestones reflect China Medical System Holdings Ltd's commitment to excellence and its position as a leading player in the pharmaceutical industry.

What is the history and background of the company China Medical System Holdings?

China Medical System Holdings Ltd is a leading pharmaceutical company in China, specializing in the marketing, promotion, and distribution of medical products. Established in 1995, the company has a rich history of over 25 years. China Medical System Holdings Ltd has successfully built relationships with numerous international pharmaceutical companies and local distributors to penetrate the Chinese market. With a focus on respiratory, cardiovascular, and infectious diseases, the company has achieved significant growth and expansion. Through its dedication to innovation, quality products, and strong partnerships, China Medical System Holdings Ltd has become a trusted name in the Chinese pharmaceutical industry.

Who are the main competitors of China Medical System Holdings in the market?

The main competitors of China Medical System Holdings Ltd in the market are Shanghai Fosun Pharmaceutical Group Co., Ltd and Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. These companies provide similar healthcare products and services within China's medical industry. However, China Medical System Holdings Ltd has emerged as a strong player due to its unique product portfolio and strategic partnerships.

In which industries is China Medical System Holdings primarily active?

China Medical System Holdings Ltd is primarily active in the pharmaceutical industry. With its focus on marketing, distribution, and sales of medical and healthcare products, the company operates in various sectors, including Western medicines, Chinese medicines, and medical devices. China Medical System Holdings Ltd collaborates with international partners to bring innovative medications and therapies to the Chinese market, aiming to enhance the accessibility and quality of healthcare for the population. By leveraging its extensive network and expertise, the company strives to contribute to the advancement of medical care in China.

What is the business model of China Medical System Holdings?

The business model of China Medical System Holdings Ltd revolves around being a pharmaceutical company focused on the marketing and distribution of branded products in China's prescription drug market. The company collaborates with multinational pharmaceutical companies and licenses their products for commercialization in China. With a strong network of regional distribution centers and sales offices, China Medical System Holdings Ltd effectively promotes and sells its portfolio of prescription drugs to hospitals, clinics, and pharmacies across the country. By strategically partnering with international pharmaceutical firms and utilizing its extensive distribution channels, the company aims to provide quality healthcare solutions to the Chinese market.

What is the P/E ratio of China Medical System Holdings 2024?

The China Medical System Holdings P/E ratio is 8.75.

What is the P/S ratio of China Medical System Holdings 2024?

The China Medical System Holdings P/S ratio is 1.93.

What is the AlleAktien quality score of China Medical System Holdings?

The AlleAktien quality score for China Medical System Holdings is 8/10.

What is the revenue of China Medical System Holdings 2024?

The expected China Medical System Holdings revenue is 8 B CNY.

How high is the profit of China Medical System Holdings 2024?

The expected China Medical System Holdings profit is 1.77 B CNY.

What is the business model of China Medical System Holdings

China Medical System Holdings Ltd (CMS) is a Chinese company specializing in the manufacturing, distribution, and marketing of pharmaceutical products. It was founded in 1995 and is headquartered in Shenzhen, China. CMS is listed on the Hong Kong Stock Exchange and is one of the leading suppliers of drugs in China. CMS divides its portfolio into three segments: innovative products, classics, and other products. Innovative products include drugs developed by CMS or its subsidiaries. Classics are generic drugs that are already established in the Chinese market and are generally used to treat chronic conditions. Other products include dietary supplements and medical devices. CMS also operates a distribution network consisting of sales teams in each province of China. These teams work closely with doctors, pharmacists, and hospitals to market products to end consumers. CMS also has a strong online presence and sells its products through e-commerce platforms such as Tmall and JD.com. CMS works closely with academics and researchers to advance product development. The company also operates its own research center focusing on the exploration of new drugs and technologies. CMS has partnered with other companies and research institutions in China and worldwide to drive innovation in the field of medicine. Another important business area for CMS is the licensing of products from other countries. The company has partnered with international pharmaceutical companies such as AstraZeneca and Roche to market their products in China. CMS has also partnered with Japanese company Kaneka Corporation to distribute their products in China. CMS has experienced strong growth in recent years and aims to expand internationally. The company has already opened branches in Hong Kong, Taiwan, Macau, and the United States, and plans to expand its presence in other countries. CMS has also announced plans to expand into other areas such as diagnostics and medical technology. In summary, the business model of China Medical System Holdings Ltd focuses on the manufacturing, marketing, and distribution of drugs, dietary supplements, and medical devices. The company has a strong online presence, a distribution network in every province of China, and works closely with other companies and research institutions to drive innovation. CMS has experienced strong growth in recent years and plans to expand internationally.

What is the China Medical System Holdings dividend?

China Medical System Holdings pays a dividend of 0.62 CNY distributed over payouts per year.

How often does China Medical System Holdings pay dividends?

The dividend cannot currently be calculated for China Medical System Holdings or the company does not pay out a dividend.

What is the China Medical System Holdings ISIN?

The ISIN of China Medical System Holdings is KYG211081248.

What is the China Medical System Holdings WKN?

The WKN of China Medical System Holdings is A1JLYP.

What is the China Medical System Holdings ticker?

The ticker of China Medical System Holdings is 867.HK.

How much dividend does China Medical System Holdings pay?

Over the past 12 months, China Medical System Holdings paid a dividend of 0.62 CNY . This corresponds to a dividend yield of about 9.76 %. For the coming 12 months, China Medical System Holdings is expected to pay a dividend of 0.69 CNY.

What is the dividend yield of China Medical System Holdings?

The current dividend yield of China Medical System Holdings is 9.76 %.

When does China Medical System Holdings pay dividends?

China Medical System Holdings pays a quarterly dividend. This is distributed in the months of June, June, September, September.

How secure is the dividend of China Medical System Holdings?

China Medical System Holdings paid dividends every year for the past 17 years.

What is the dividend of China Medical System Holdings?

For the upcoming 12 months, dividends amounting to 0.69 CNY are expected. This corresponds to a dividend yield of 10.97 %.

In which sector is China Medical System Holdings located?

China Medical System Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von China Medical System Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China Medical System Holdings from 9/9/2024 amounting to 0.02 CNY, you needed to have the stock in your portfolio before the ex-date on 8/30/2024.

When did China Medical System Holdings pay the last dividend?

The last dividend was paid out on 9/9/2024.

What was the dividend of China Medical System Holdings in the year 2023?

In the year 2023, China Medical System Holdings distributed 0.616 CNY as dividends.

In which currency does China Medical System Holdings pay out the dividend?

The dividends of China Medical System Holdings are distributed in CNY.

Scope 1 - Direct Emissions	1,628.4
Scope 2 - Indirect emissions from purchased energy	4,131
Scope 3 - Indirect emissions within the value chain	4,336.6
Total CO₂ emissions	5,759.4
CO₂ reduction strategy	✅
Coal energy	❌
Nuclear power	❌
Animal experiments	❌
Fur & Leather	—
Pesticides	—
Palm Oil	—
Tobacco	❌
Genetically modified organisms	❌
Climate concept	—
Sustainable forestry	—
Recycling regulations	❌
Environmentally friendly packaging	✅
Hazardous substances	✅
Fuel consumption and efficiency	✅
Water consumption and efficiency	✅

Percentage of female employees	54.8
Percentage of women in management	—
Percentage of Asian employees	—
Share of Asian management	—
Percentage of Hispanic/Latino employees	—
Hispano/Latino Management share	—
Percentage of Black employees	—
Black Management Share	—
Percentage of white employees	—
White Management Share	—
Adult content	❌
Alcohol	❌
Weapons	—
Firearms	❌
Gambling	❌
Military contracts	❌
Human rights concept	✅
Privacy concept	—
Occupational health and safety	✅
Catholic	✅

Environmental reporting	✅
Stakeholder Engagement	✅
Call Back Policies	❌
Antitrust law	❌

Stock Exchange	China Medical System Holdings Ticker
DÜSSELDORF	2M7C.DU
FRANKFURT	2M7C.F
HKSE	0867.HK
MUNICH	2M7C.MU
PNK	CHSYF

China Medical System Holdings Ticker	China Medical System Holdings FIGI
CMSH:EO	BBG000QD7KQ2
CMSH:E1	BBG000QD7TT0
CMSH:XT	BBG000QD7VH8
CMSH:XW	BBG000QD7W77
CMSH:EU	BBG000QD7X84
867:HK	BBG0015X4QW2
2M7C:GR	BBG00162N8Z5
2M7C:GF	BBG00162N910
2M7C:GD	BBG00162N929
2M7C:GS	BBG00162N947
2M7C:GM	BBG00162N956
2M7C:GB	BBG00162N965
CHSYF:US	BBG003TRKFF0
CHSYF:PQ	BBG003TRKFV2
CHSYF:UV	BBG003TRKFX0
2M7C:TH	BBG004GWK3H6
CMSH:XV	BBG005919KN7
867:H1	BBG006Z3JPT4
CMSHEUR:EO	BBG008G2QD03
CMSHEUR:XH	BBG008G2QD30
CMSHEUR:XF	BBG008G2QD58
CMSHEUR:XE	BBG008G2QD76
CMSHEUR:XJ	BBG008G2QD85
CMSHEUR:XL	BBG008G2QD94
CMSHEUR:XG	BBG008G2QDB1
CMSHEUR:XO	BBG008G2QDC0
CMSHEUR:XS	BBG008G2QDH5
CMSHEUR:XA	BBG008G2QDJ3
CMSHEUR:E1	BBG008G2QDK1
CMSHEUR:XT	BBG008G2QDL0
CMSHEUR:XW	BBG008G2QDM9
CMSHEUR:XU	BBG008G2QDN8
CMSHEUR:XV	BBG008G2QDQ5
CMSHEUR:EU	BBG008G2QDV9
2M7C:QT	BBG00CTTG9H3
867:H2	BBG00F1355M7
CMSH:XX	BBG00JN776H8
CMSHEUR:XX	BBG00JN8D9F5
867N:L3	BBG00JRFH1G7
867N:B3	BBG00JRFNHR3
867N:PO	BBG00JRFV1V4
CMSHHKD:X2	BBG00JRGJSB9
CMSHHKD:XB	BBG00JRGJSC8
CMSHHKD:XH	BBG00JRGJSF5
CMSHHKD:XF	BBG00JRGJSH3
CMSHHKD:XE	BBG00JRGJSK9
CMSHHKD:XJ	BBG00JRGJSL8
CMSHHKD:XL	BBG00JRGJSM7
CMSHHKD:XG	BBG00JRGJSN6
CMSHHKD:XO	BBG00JRGJSP4
CMSHHKD:XS	BBG00JRGJST0
CMSHHKD:XA	BBG00JRGJSV7
CMSHHKD:E1	BBG00JRGJSW6
CMSHHKD:XT	BBG00JRGJSX5
CMSHHKD:XW	BBG00JRGJSY4
CMSHHKD:XU	BBG00JRGJSZ3
CMSHHKD:XV	BBG00JRGJT09
CMSHHKD:XM	BBG00JRGJT18
CMSHHKD:XQ	BBG00JRGJT36
CMSHHKD:XX	BBG00JRGJT45
CMSHHKD:XZ	BBG00JRGJT54
CMSHHKD:EU	BBG00JRGJT72
2M7C:GZ	BBG00X2S7G82
CMSHEUR:EP	BBG00X2THX91
CMSHEUR:EZ	BBG00X2THXC7
867N:L1	BBG00Y7B0HC2
2M7C:LA	BBG018H93YJ5
2M7C:LU	BBG018J2RZD5

2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e	2027e
0.23	0.27	0.3	0.39	0.5	0.66	0.89	1.36	1.78	2.25	2.95	3.55	4.9	5.35	5.43	6.07	6.95	8.34	9.15	8.01	8	9.15	10.7	12.73
-	19.38	10.70	31.00	28.24	30.56	35.87	52.01	30.83	26.49	30.95	20.65	37.91	9.14	1.59	11.78	14.36	20.04	9.75	-12.43	-0.19	14.44	16.88	18.99
76.21	74.17	68.67	64.89	61.71	63.07	59.06	56.59	58.83	54.51	56.16	57.59	59.41	65.03	72.08	74.86	73.92	74.92	76.89	76.24	-	-	-	-
0.17	0.2	0.21	0.26	0.31	0.42	0.53	0.77	1.05	1.23	1.65	2.05	2.91	3.48	3.92	4.55	5.13	6.25	7.04	6.11	0	0	0	0
0.05	0.06	0.04	0.09	0.13	0.19	0.24	0.4	0.58	0.7	1.12	1.07	1.55	1.9	2.01	2.4	2.81	3.22	3.64	2.72	2.06	2.43	3.4	4
21.15	20.30	14.67	23.41	25.40	28.42	26.51	29.58	32.62	31.17	37.96	30.09	31.53	35.45	37.05	39.59	40.43	38.59	39.76	33.88	25.73	26.54	31.73	31.40
0.03	0.04	0.03	0.07	0.1	0.14	0.21	0.4	0.54	0.64	1.05	1	1.38	1.67	1.85	1.96	2.53	3.02	3.26	2.4	1.77	2.04	2.85	3.29
-	37.93	-20.00	106.25	56.06	36.89	46.81	94.20	33.33	18.66	64.31	-4.78	38.19	21.75	10.45	6.00	29.08	19.25	7.99	-26.34	-26.33	15.33	39.73	15.58
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
1.42	1.42	1.42	1.31	1.42	1.43	2	2.36	2.41	2.41	2.41	2.47	2.49	2.49	2.49	2.48	2.47	2.47	2.45	2.45	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Own the gold standard ✨ in financial data & analytics fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Price

Price

Ticker867.HK

ISINKYG211081248

WKNA1JLYP

China Medical System Holdings stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

China Medical System Holdings Stock Price History

China Medical System Holdings Revenue, EBIT, Net Income KYG211081248 · A1JLYP

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

China Medical System Holdings Revenue, EBIT and net profit per share

China Medical System Holdings Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

China Medical System Holdings stock margins KYG211081248 · A1JLYP

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

China Medical System Holdings Margin History

China Medical System Holdings Stock Sales Revenue, EBIT, Earnings per Share KYG211081248 · A1JLYP

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

China Medical System Holdings Revenue, EBIT and net profit per share

China Medical System Holdings business model

China Medical System Holdings SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

China Medical System Holdings Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

China Medical System Holdings historical P/E ratio, EBIT, and P/S ratio.

China Medical System Holdings shares outstanding KYG211081248 · A1JLYP

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

China Medical System Holdings Stock splits

China Medical System Holdings dividend history and estimates KYG211081248 · A1JLYP

Dividend

Dividend Overview

Interpretation and Use

Investment Strategy

China Medical System Holdings Dividend History

China Medical System Holdings dividend payout ratio KYG211081248 · A1JLYP

Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Ticker
867.HK

ISIN
KYG211081248

WKN
A1JLYP